InterVenn Biosciences Inc.
Overview
InterVenn Biosciences is a biotechnology company that leverages its proprietary glycoproteomics technology to transform the diagnosis and treatment of cancer and other diseases. The company provides novel insights into the biology of glycosylation, offering breakthroughs in predictive, non-invasive tests and therapies.
Therapeutic areas
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to InterVenn Biosciences Inc. in our records. PharmaTek screens the full directory against live FDA enforcement data.
Is this InterVenn Biosciences Inc.? Get in front of buyers actively sourcing.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.